Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment (Detail)

v3.21.2
Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment (Detail) - USD ($)
 3 Months Ended 6 Months Ended
May 31, 2021
May 31, 2020
May 31, 2021
May 31, 2020
Nov. 30, 2020
Segment Reporting Information [Line Items]          
Total net revenue $ 7,205,195 $ 7,871,844 $ 14,065,812 $ 15,492,618  
Total cost of sales 2,222,671 2,480,543 4,234,868 4,983,687  
Total depreciation and amortization 267,422 43,303 288,685 87,524  
Total operating income 1,995,068 1,752,186 3,230,329 3,001,256  
Total interest expense 341,390 365,371 621,609 730,670  
Total assets 58,318,412   58,318,412   $ 46,200,094
Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Total depreciation and amortization 267,422 43,303 288,685 87,524  
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]          
Segment Reporting Information [Line Items]          
Total net revenue 7,158,886 7,600,902 13,897,517 15,007,190  
Total cost of sales 1,869,769 1,966,441 3,509,784 4,021,515  
Total operating income 2,308,856 2,002,877 3,801,209 3,492,424  
Total interest expense 341,390 365,371 621,609 730,670  
Total assets 46,465,499   46,465,499   34,215,780
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Total depreciation and amortization 260,226 36,408 274,594 73,735  
PrepaCyte CB [Member]          
Segment Reporting Information [Line Items]          
Total net revenue   57,300 38,000 117,707  
Total cost of sales 41,203 32,014 76,084 73,131  
Total operating income (48,097) 17,984 (51,873) 30,379  
Total assets 283,830   283,830   302,683
PrepaCyte CB [Member] | Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Total depreciation and amortization 6,894 6,895 13,789 13,789  
Public Cord Blood Banking [Member]          
Segment Reporting Information [Line Items]          
Total net revenue 46,309 213,642 130,295 367,721  
Total cost of sales 311,699 482,088 649,000 889,041  
Total operating income (265,691) $ (268,675) (519,007) $ (521,547)  
Total assets 11,569,083   11,569,083   $ 11,681,631
Public Cord Blood Banking [Member] | Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Total depreciation and amortization $ 302   $ 302